These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9186564)

  • 41. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
    Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
    J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
    Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
    Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.
    Chapman KT; Kopka IE; Durette PL; Esser CK; Lanza TJ; Izquierdo-Martin M; Niedzwiecki L; Chang B; Harrison RK; Kuo DW
    J Med Chem; 1993 Dec; 36(26):4293-301. PubMed ID: 8277511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of arylidene-substituted gelastatin analogues and their screening for MMP-2 inhibitory activity.
    Kim EJ; Ko SY
    Bioorg Med Chem; 2005 Jun; 13(12):4103-12. PubMed ID: 15911325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
    Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
    Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
    [No Abstract]   [Full Text] [Related]  

  • 46. Xylaropyrones B and C, new γ-pyrones from the endophytic fungus Xylaria sp. SC1440.
    Guo C; Wu P; Xue J; Li H; Wei X
    Nat Prod Res; 2018 Jul; 32(13):1525-1531. PubMed ID: 29022356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of cytostatin analogues.
    Bialy L; Waldmann H
    Chem Commun (Camb); 2003 Aug; (15):1872-3. PubMed ID: 12932009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Green tea polyphenols inhibit metalloproteinase activities in the skin, muscle, and blood of rainbow trout.
    Saito M; Saito K; Kunisaki N; Kimura S
    J Agric Food Chem; 2002 Nov; 50(24):7169-74. PubMed ID: 12428978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New leads to cancer, arthritis therapies.
    Hagmann M
    Science; 1999 Jun; 284(5420):1600-1. PubMed ID: 10383332
    [No Abstract]   [Full Text] [Related]  

  • 50. Structure-function relationships in the tissue inhibitors of metalloproteinases.
    Willenbrock F; Murphy G
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S165-70. PubMed ID: 7952654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template.
    Groneberg RD; Burns CJ; Morrissette MM; Ullrich JW; Morris RL; Darnbrough S; Djuric SW; Condon SM; McGeehan GM; Labaudiniere R; Neuenschwander K; Scotese AC; Kline JA
    J Med Chem; 1999 Feb; 42(4):541-4. PubMed ID: 10052961
    [No Abstract]   [Full Text] [Related]  

  • 52. Release of gelatinase A during platelet activation mediates aggregation.
    Sawicki G; Salas E; Murat J; Miszta-Lane H; Radomski MW
    Nature; 1997 Apr; 386(6625):616-9. PubMed ID: 9121586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
    Szardenings AK; Harris D; Lam S; Shi L; Tien D; Wang Y; Patel DV; Navre M; Campbell DA
    J Med Chem; 1998 Jun; 41(13):2194-200. PubMed ID: 9632351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins.
    Tamaki K; Tanzawa K; Kurihara S; Oikawa T; Monma S; Shimada K; Sugimura Y
    Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1883-93. PubMed ID: 8575029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational analyses of thiirane-based gelatinase inhibitors.
    Lee M; Hesek D; Shi Q; Noll BC; Fisher JF; Chang M; Mobashery S
    Bioorg Med Chem Lett; 2008 May; 18(10):3064-7. PubMed ID: 18083555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Total synthesis and cytoprotective properties of dykellic acid.
    Thompson CM; Quinn CA; Hergenrother PJ
    J Med Chem; 2009 Jan; 52(1):117-25. PubMed ID: 19072121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates.
    Delong RK; Miller PS
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):273-80. PubMed ID: 9012863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues.
    Brown FK; Brown PJ; Bickett DM; Chambers CL; Davies HG; Deaton DN; Drewry D; Foley M; McElroy AB; Gregson M
    J Med Chem; 1994 Mar; 37(5):674-88. PubMed ID: 8126708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.